Is FMS undervalued? Intrinsic value estimate stands at $70.
Get informed when a big investor buys or sells
+ Follow$69.92
Undervalued by 214.9% based on the discounted cash flow analysis.
Fresenius Medical Care AG (FMS) currently reports a DCF fair value of $70. Use the charts on this page to explore Fresenius Medical Care AG's DCF fair value history and peer comparisons.
Fresenius Medical Care AG's discounted cash flow (DCF) fair value estimate is $70, about 214.9% undervalued versus the current market price. DCF models project future free cash flows and discount them back to today — so the result depends on growth, margin, and discount-rate assumptions. Use it as one valuation lens alongside multiples and peer checks on Stockcircle.
Start with the current DCF fair value of $70, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fresenius Medical Care AG, and consider following FMS for alerts when major investors trade the stock.
Fresenius Medical Care AG is classified in the Healthcare sector. On DCF fair value, it currently shows $70. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FMS with unrelated industries.